27568206|t|AKT / GSK3β Signaling in Glioblastoma
27568206|a|Glioblastoma (GBM) is the most aggressive of primary brain tumors. Despite the progress in understanding the biology of the pathogenesis of glioma made during the past decade, the clinical outcome of patients with GBM remains still poor. Deregulation of many signaling pathways involved in growth, survival, migration and resistance to treatment has been implicated in pathogenesis of GBM. One of these pathways is phosphatidylinositol-3 kinases (PI3K)/protein kinase B (AKT) / rapamycin-sensitive mTOR-complex (mTOR) pathway, intensively studied and widely described so far. Much less attention has been paid to the role of glycogen synthase kinase 3 β (GSK3β), a target of AKT. In this review we focus on the function of AKT / GSK3β signaling in GBM.
27568206	0	3	AKT	T116,T126	C0164786
27568206	6	11	GSK3β	T116,T126	C0244988
27568206	12	21	Signaling	T044	C0037080
27568206	25	37	Glioblastoma	T191	C0017636
27568206	38	50	Glioblastoma	T191	C0017636
27568206	52	55	GBM	T191	C0017636
27568206	91	103	brain tumors	T191	C0006118
27568206	147	154	biology	T091	C0005532
27568206	162	174	pathogenesis	T046	C0699748
27568206	178	184	glioma	T191	C0017638
27568206	218	234	clinical outcome	T034	C0456984
27568206	238	246	patients	T101	C0030705
27568206	252	255	GBM	T191	C0017636
27568206	270	274	poor	T080	C0542537
27568206	276	288	Deregulation	T052	C1880287
27568206	297	315	signaling pathways	T044	C0037080
27568206	328	334	growth	T191	C1516170
27568206	336	344	survival	T169	C0220921
27568206	346	355	migration	T191	C0027627
27568206	360	370	resistance	T169	C4281815
27568206	374	383	treatment	T061	C0087111
27568206	407	419	pathogenesis	T046	C0699748
27568206	423	426	GBM	T191	C0017636
27568206	441	449	pathways	T044	C0037080
27568206	453	513	phosphatidylinositol-3 kinases (PI3K)/protein kinase B (AKT)	T169	C2984369
27568206	516	563	rapamycin-sensitive mTOR-complex (mTOR) pathway	T044	C1515673
27568206	663	691	glycogen synthase kinase 3 β	T116,T126	C0244988
27568206	693	698	GSK3β	T116,T126	C0244988
27568206	713	716	AKT	T116,T126	C0164786
27568206	749	757	function	T169	C0542341
27568206	761	764	AKT	T116,T126	C0164786
27568206	767	772	GSK3β	T116,T126	C0244988
27568206	773	782	signaling	T044	C0037080
27568206	786	789	GBM	T191	C0017636